Development of a multiplex assay to characterize ADAMTS13 structure and function

Keyphrases

• ADAMTS13 100%
• Multiplex Assay 100%
• Binding Site 14%
• Cleavage Rate 14%
• Recombinant ADAMTS13 14%
• Multiplex 9%
• Metalloprotease 9%
• Cattle 9%
• ADAMTS13 Protein 9%
• HEK293 Cells 9%
• Induced Activation 4%
• Post-translational Modification 4%
• Cysteine 4%
• Amino 4%
• Autoimmune 4%
• Life-threatening 4%
• Disease States 4%
• Peptide Substrate 4%
• Thrombotic Thrombocytopenic Purpura 4%
• Thrombospondin-1 (TSP-1) 4%
• S-Domain 4%
• Disintegrin-like 4%
• Substrate-induced 4%
• Mutagenesis 4%
• CUB Domain 4%
• Sequence Modification 4%
• Vascular Thrombosis 4%
• Recombinant Human 4%
• Protein Sequence 4%
• Fluorogenic Substrate 4%
• FRET Substrates 4%
• Disease-causing mutations 4%
• Activity Method 4%
• Into the Wild 4%
• Structural Perturbation 4%
• Variant Proteins 4%
• Multisubstrate 4%
• Animal Plasma 4%
• Recombinant Variants 4%

Biochemistry, Genetics and Molecular Biology

• ADAMTS13 100%
• Von Willebrand Factor 20%
• Blood Plasma 16%
• Wild Type 12%
• Binding Site 12%
• Bovine 8%
• Metalloproteinase 8%
• Posttranslational Modification 4%
• Peptide Sequence 4%
• Genetics 4%
• Recombinant 4%
• Fluorescence Resonance Energy Transfer 4%
• Thrombotic Thrombocytopenic Purpura 4%
• Thrombospondin 1 4%
• Mutagenesis 4%
• Disintegrin 4%
• Cysteine 4%